Alamast

Active Ingredient(s): Pemirolast
FDA Approved: * September 24, 1999
Pharm Company: * SANTEN
Category: Allergies, Cough & Cold

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".



Alamast Overview

Pemirolast (INN) is a mast cell stabilizer used as an anti-allergic drug therapy. It is marketed under the tradenames Alegysal and Alamast. Clinical trials studying treatments for allergic conjunctivitis have found that an ophthalmic solution containing levocabastine with pemirolast potassium may be more effective in alleviating symptoms than levocabastine alone.[1] It has also been studied for the treatment of asthma. References ^ Castillo M, Scott NW, Mustafa MZ, Musta...

Read more Alamast Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Pemirolast

Recent Alamast Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

Pemirolast
  • Solution: 0.1%
  • Solution/drops: 0.1%, 0.10%
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

NDC Database Records for Alamast: (1 result)

Sorted by National Drug Code
  • 68669-711 Alamast 1 mg/ml Ophthalmic Solution by Vistakon Pharmaceuticals LLC

Other drugs which contain Pemirolast or a similar ingredient: (1 result)






Note: All times displayed are GMT - 7.

This information has been independently compiled and is for informational purposes only. It is not intended to be a substitute for medical advice from a qualified healthcare professional; nor is it intended to diagnose, treat, cure or prevent any disease. For more details please see the Medical Disclaimer. This page was last updated on 19 December 2018.

We are committed to your privacy.

Copyright © 2005-2018 All Rights Reserved. MedsChat® is a registered trademark of Limelight Innovations L.L.C. 9888 W Belleview Ave #5000, Denver, CO, 80123, USA